SQRX — Squarex Pharmaceutical Balance Sheet
0.000.00%
Consumer DefensivesMicro Cap
Annual balance sheet for Squarex Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 0.005 | 0.035 | 0.005 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 0.005 | 0.073 | 0.024 |
| Net Property, Plant And Equipment | 0 | 0.015 | 0 |
| Total Assets | 0.005 | 0.088 | 0.024 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.203 | 0.368 | 0.466 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 0.51 | 0.903 | 1.17 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | -0.505 | -0.816 | -1.14 |
| Total Liabilities & Shareholders' Equity | 0.005 | 0.088 | 0.024 |
| Total Common Shares Outstanding |